{
    "clinical_study": {
        "@rank": "88978", 
        "acronym": "CLEAN-TAVI", 
        "arm_group": [
            {
                "arm_group_label": "Cerebral Protection Filter", 
                "arm_group_type": "Other", 
                "description": "Patient is treated with Cerebral protection Filter."
            }, 
            {
                "arm_group_label": "No Cerebral Protection Filter", 
                "arm_group_type": "Other", 
                "description": "Patient is not treated with Cerebral protection Filter."
            }
        ], 
        "brief_summary": {
            "textblock": "This prospective, randomized study was designed to investigate the benefit of using a\n      Filter-Protection-Device (Claret MontageTM Dual Filter System) during transcatheter aortic\n      valve implantation (TAVI) with a Medtronic CoreValve\u00ae."
        }, 
        "brief_title": "CLaret Embolic Protection ANd TAVI - Trial", 
        "condition": [
            "Frequency of Cerebral Perfusion Defects After TAVI", 
            "Size of Cerebral Perfusion Defects After TAVI"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject must be scheduled to undergo an endovascular aortic valve prosthesis\n             (Medtronic CoreValve\u00ae) implant procedure with the femoral artery as the intended\n             access site for the valve delivery system.\n\n        Exclusion Criteria:\n\n          -  Patient is unsuitable for TAVI\n\n          -  Prior Stroke or TIA in the last 12 month\n\n          -  Carotic stenosis >70%\n\n          -  Relevant stenosis of the brachiocephalic trunc or the right subclavian artery\n\n          -  Expected Non-compliance for follow-ups\n\n          -  Pregnancy\n\n          -  Patient is already recruited for another study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01833052", 
            "org_study_id": "HZL-01-TAVI"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Cerebral Protection Filter", 
                    "No Cerebral Protection Filter"
                ], 
                "intervention_name": "TAVI (Medtronic CoreValve)", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Cerebral Protection Filter", 
                "intervention_name": "Claret-Filter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 15, 2013", 
        "location": {
            "contact": {
                "email": "linkea@medizin.uni-leipzig.de", 
                "last_name": "Axel Linke, Prof. Dr. med.", 
                "phone": "0049 341 865 25 2016"
            }, 
            "contact_backup": {
                "email": "hast@med.uni-leipzig.de", 
                "last_name": "Stephan Haussig, Dr. med.", 
                "phone": "0049 341 865 252515"
            }, 
            "facility": {
                "address": {
                    "city": "Leipzig", 
                    "country": "Germany", 
                    "zip": "04289"
                }, 
                "name": "Leipzig Herzzentrum"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary endpoint ist the rate and the size of cerebral embolism in postinterventional Magnetic Resonance Imaging (MRI).", 
            "measure": "Rate and Size of Cerebral Embolism", 
            "safety_issue": "No", 
            "time_frame": "2 days after Intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01833052"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Leipzig", 
            "investigator_full_name": "Prof. Dr. med. A. Linke", 
            "investigator_title": "Prof. Dr. med. A. Linke", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Leipzig", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Leipzig", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}